Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8312769 | Clinica Chimica Acta | 2013 | 8 Pages |
Abstract
There is an urgent need to standardize the way manufacturers test and report their data on the lipemia interference. We propose that, instead of arbitrary limits, manufacturers use evidence based quality specifications for assessing the allowable biases. Moreover, laboratories should be aware of the possible lack of replicability of manufacturers' declarations.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Nora Nikolac, Ana-Maria Simundic, Manuela Miksa, Gabriel Lima-Oliveira, Gian Luca Salvagno, Beatrice Caruso, Gian Cesare Guidi,